Asia-Pacific Drug Discovery Informatics Market Reaches $729.5 Million in 2025 with 10.4% CAGR

Asia-Pacific drug discovery informatics market was valued at $729.5 million in 2025 and is projected to reach $1,950.5 million by 2035, growing at a CAGR of 10.4% during the forecast period (2026–2035). Drug discovery informatics encompasses the application of computational tools, databases, and advanced analytics to accelerate and optimize the drug development process, including molecular modeling, docking, virtual screening, sequencing and target data analysis, and library and database management. The market is witnessing robust growth across the Asia-Pacific region, driven by expanding pharmaceutical and biotechnology R&D activities, rising investments in precision medicine, and increasing adoption of AI- and cloud-based informatics platforms. Countries such as China, India, Japan, South Korea, and Australia are strengthening their drug discovery ecosystems through government-backed research programs, growing clinical trial activity, and the expansion of contract research organizations (CROs), collectively supporting demand for advanced informatics solutions.

 Browse the full report description of “Asia-Pacific Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others) Forecast Period, (2026-2035)” of https://www.omrglobal.com/industry-reports/asia-pacific-drug-discovery-informatics-market

 According to NCBI and the UNESCO Institute for Statistics, the Asia-Pacific region has become a major global hub for data-driven drug discovery, supported by rapid growth in genomic sequencing, structural biology, and life-science research output. Publicly accessible databases maintained by NCBI and international research statistics published by UNESCO indicate that Asia-Pacific countries contribute a substantial share of global biomedical data used in drug discovery informatics, including molecular modeling, docking, sequencing, and compound library development.

 Key Innovators Driving Asia-Pacific Drug Discovery Informatics Transformation

The key players in the Asia-Pacific drug discovery informatics market include Charles River Laboratories International, Inc, Dassault Systèmes, Eurofins Scientific SE, PerkinElmer, Inc., Thermo Fisher Scientific Inc, among others. These companies are focusing on advanced modeling and simulation platforms, data-driven drug design tools, and integrated informatics solutions, playing a critical role in transforming drug discovery workflows and shaping the future of pharmaceutical research across the Asia-Pacific region.

• In May 2025, XtalPi, a China-based AI-driven drug discovery company, announced a significant capital raise to advance its “AI + Technology and Industry Integration Innovation Consortium Project” in the Greater Bay Area. The initiative highlights increasing investor confidence in informatics-led drug discovery and enhances regional infrastructure for computational drug design.
• In April 2024, Aurigene Pharmaceutical Services of India introduced Aurigene.AI, a new platform delivering AI and machine learning–enabled discovery services to accelerate drug development from hit identification to lead optimization, reflecting the growing adoption of advanced informatics across the Indian biotech sector.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Function
  • By End-Users
• Competitive Landscape - Charles River Laboratories International, Inc, Dassault Systèmes, Eurofins Scientific SE, PerkinElmer, Inc., Thermo Fisher Scientific Inc, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Asia-Pacific Drug Discovery Informatics Market Report Segment

By Function

• Docking
• Molecular Modeling
• Libraries & Database Preparation
• Sequencing & Target Data Analysis
• Others

By End-Users

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Others

Asia-Pacific Drug Discovery Informatics Market Report Segment by Region

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

 To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-drug-discovery-informatics-market